Colonic mucosal cell

Colonic mucosal cells constitute the innermost epithelial lining of the large intestine, primarily composed of absorptive colonocytes, goblet cells, and enteroendocrine cells. These cells serve a vital physiological role by absorbing water and electrolytes, synthesizing a protective mucus barrier, and facilitating a symbiotic relationship with the gut microbiota (Source: StatPearls, Histology, Large Intestine). In clinical pathology, the dysfunction of these cells is a primary driver of Inflammatory Bowel Disease (IBD), where a breakdown in the mucosal barrier leads to chronic inflammation, and in colorectal cancer, where epithelial cells undergo malignant transformation (Source: NIH, NIDDK). While many therapeutic agents like 5-aminosalicylates and monoclonal antibodies are designed to treat diseases of the colon, they target specific molecular pathways (such as TNF-alpha or integrins) rather than the cell as a single receptor. Therefore, 'colonic mucosal cells' refers to a complex tissue system and site of drug action rather than a discrete therapeutic target molecule (Source: PubChem, Mesalamine).

Other names

ColonocyteColonic epithelial cellIntestinal mucosal cellLarge intestine epithelial cell

Drugs targeting the colonic mucosa typically work by inhibiting pro-inflammatory cytokines (e.g., TNF-alpha), blocking leukocyte adhesion to the vascular endothelium (e.g., alpha-4 beta-7 integrin antagonism), or modulating intracellular signaling pathways like the JAK-STAT pathway to reduce epithelial inflammation and promote mucosal healing (Source: PubMed, PMID: 31076503).